ClearPoint Neuro (CLPT) Convertible Debt (2011 - 2012)
ClearPoint Neuro (CLPT) reported Convertible Debt of $2.0 million for Q4 2012, down 39.55% on a YoY basis from $3.3 million in Q1 2012, and little changed sequentially from $2.0 million in Q3 2012.
ClearPoint Neuro (CLPT) Convertible Debt (2011 - 2012) Analysis & Trends
ClearPoint Neuro (CLPT) has 2 years of Convertible Debt data on file, last reported at $2.0 million in Q4 2012.
- For the quarter ending Q4 2012, Convertible Debt fell 39.55% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2012 stood at $2.0 million (down 39.55% YoY), and the FY2012 full-year result was $2.0 million, down 39.55% from the prior year.
- Convertible Debt held at $2.0 million in Q4 2012, from $2.0 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $3.3 million in Q4 2011 to a low of $2.0 million in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 2.00 Mn |
| Sep 30, 2012 | 2.00 Mn |
| Jun 30, 2012 | 2.00 Mn |
| Mar 31, 2012 | 2.00 Mn |
| Dec 31, 2011 | 3.31 Mn |